Parnax Lab Share Price | Parnax Lab Stock Screener
PARNAXLAB
Pharmaceuticals
Share Price BSE
₹146.35
▲
2.30 (1.60%)
As of July 3, 2026, the Parnax Lab share price (BSE: PARNAXLAB) is ₹146.35, up 1.60% from the previous close, with shares trading between ₹140.35 and ₹155.00, and a 52-week range of ₹101.05–₹165.00.
Analyse PARNAXLAB price movement history and track historical price performance.
Use the Parnax Lab stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Parnax Lab Market Cap
₹153.80 Cr.
PARNAXLAB P/E Ratio (TTM)
13.04
Parnax Lab P/B Ratio
1.62
EPS (TTM)
₹10.27
Dividend Yield
-
Debt to Equity
0.97
PARNAXLAB 52 Week High
₹165.00
Parnax Lab 52 Week Low
₹101.05
Operating Margin
7.00%
Profit Margin
2.78%
PARNAXLAB Revenue (TTM)
₹72.00
EBITDA
₹7.00
Net Income
₹2.00
Total Assets
₹228.00
Total Equity
₹95.00
Parnax Lab Share Price Chart
Screen Parnax Lab share price with an interactive chart. Analyse PARNAXLAB price trends and volatility across different timeframes.
Parnax Lab Company Profile - Fundamental Screener
Screen Parnax Lab company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for PARNAXLAB shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE383L01019
Parnax Lab Balance Sheet Screener
Screen PARNAXLAB balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 228 | 190 | 190 | 145 | 154 | 106 | 107 | 95 | 87 | 86 |
| Current Assets | 91 | 65 | 73 | 57 | 71 | 39 | 46 | 37 | 37 | 31 |
| Fixed Assets | 126 | 88 | 90 | 77 | 72 | 60 | 58 | 51 | 44 | 47 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 37 | 32 | 35 | 20 | 24 | 19 | 22 | 23 | 18 | 18 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 95 | 83 | 72 | 62 | 48 | 33 | 33 | 36 | 33 | 31 |
| Share Capital | 12 | 12 | 12 | 12 | 10 | 9 | 9 | 9 | 9 | 9 |
| Reserves & Surplus | 84 | 72 | 60 | 51 | 37 | 24 | 24 | 27 | 24 | 23 |
Parnax Lab Income Statement Screener - Profit & Revenue Analysis
Screen Parnax Lab income statement and profit fundamentals.
Analyze PARNAXLAB quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Parnax Lab share price evaluation.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 72 | 50 | 54 | 63 | 64 | 47 | 50 | 49 | 40 | 41 | 49 | 43 | 51 | 48 | 37 |
| Expenses | 65 | 42 | 46 | 55 | 57 | 41 | 42 | 41 | 36 | 36 | 42 | 37 | 45 | 41 | 31 |
| EBITDA | 7 | 7 | 8 | 9 | 7 | 6 | 9 | 8 | 5 | 5 | 7 | 6 | 6 | 7 | 5 |
| Operating Profit % | 7.00% | 14.00% | 14.00% | 13.00% | 9.00% | 13.00% | 17.00% | 15.00% | 11.00% | 12.00% | 13.00% | 12.00% | 12.00% | 15.00% | 14.00% |
| Depreciation | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Interest | 2 | 1 | 1 | 1 | 2 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit Before Tax | 3 | 4 | 5 | 5 | 3 | 3 | 5 | 5 | 2 | 2 | 4 | 2 | 3 | 4 | 3 |
| Tax | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 2 | 0 | 1 | 1 | 1 | 1 | 4 | 1 |
| Net Profit | 2 | 3 | 3 | 4 | 3 | 2 | 4 | 3 | 1 | 1 | 3 | 2 | 2 | 0 | 2 |
| EPS | 1.90 | 2.55 | 2.85 | 3.15 | 2.37 | 1.95 | 3.47 | 2.97 | 1.06 | 1.30 | 2.90 | 1.63 | 1.90 | -0.18 | 1.97 |
Parnax Lab Cash Flow Screener - Liquidity Fundamentals
Screen PARNAXLAB cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 32 | 16 | 21 | 9 | 6 | 9 | 9 | 13 | 16 | 4 |
| Investing Activities | -16 | -32 | -10 | -17 | -7 | -13 | -11 | -5 | -10 | -6 |
| Financing Activities | -16 | 15 | -14 | 12 | 0 | 5 | 1 | -7 | -5 | 1 |
| Net Cash Flow | 0 | -1 | -3 | 4 | 0 | 0 | -1 | 1 | 0 | -2 |
Parnax Lab Shareholding Pattern Screener
See Parnax Lab shareholding pattern with promoter, FII, and DII holdings.
Check Parnax Lab promoter holding and ownership changes for PARNAXLAB on TickJournal.
| Item | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 72.30% | 72.30% | 72.30% | 72.30% | 72.30% | 72.30% | 72.30% | 72.30% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 23.27% | 24.37% | 24.93% | 24.97% | 24.73% | 24.68% | 24.26% | 24.60% |
| Other Holding | 4.44% | 3.33% | 2.77% | 2.74% | 2.97% | 3.02% | 3.44% | 3.11% |
| Shareholder Count | 3,721 | 3,900 | 4,111 | 4,317 | 4,440 | 4,521 | 4,173 | 4,406 |
Parnax Lab Share Dividend Screener - Share Yield Analysis
Check Parnax Lab dividend history with payout and yield data.
View Parnax Lab dividend details including ex-dates and amounts for PARNAXLAB stock.
Parnax Lab Stock Index Membership
See which indices include Parnax Lab stock.
Check PARNAXLAB index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Parnax Lab Market Events Screener - Corporate Actions
Get Parnax Lab corporate actions including splits, bonuses, and buybacks.
Check Parnax Lab stock events that may affect PARNAXLAB share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 2.57% | ||
| Annual General Meeting | NA | 1.00% | ||
| 2026-05-28 | 2026-05-28 | Quarterly Result Announcement | NA | -0.88% |
| 2026-02-13 | 2026-02-13 | Quarterly Result Announcement | NA | 1.50% |
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | 0.58% |
| 2025-08-13 | 2025-08-13 | Quarterly Result Announcement | NA | -2.47% |
| 2025-05-27 | 2025-05-27 | Quarterly Result Announcement | NA | -4.44% |
| 2025-02-10 | 2025-02-10 | Quarterly Result Announcement | NA | 2.05% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | 0.33% |
Parnax Lab Competitors Screener - Peer Comparison
Screen PARNAXLAB competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 447,764 | 38.90 | 58,220 | 6.38% | 11,565 | 61.23 |
| Divis Laboratories | 173,763 | 67.64 | 10,560 | 8.73% | 2,520 | 42.94 |
| Torrent Pharmaceuticals | 157,066 | 73.47 | 13,886 | 20.34% | 2,138 | 63.51 |
| Cipla | 117,679 | 30.48 | 29,045 | 2.24% | 3,870 | 66.61 |
| Dr Reddys Laboratories | 111,837 | 26.89 | 33,593 | -0.44% | 3,998 | 60.09 |
| Zydus Life Science | 111,612 | 21.78 | 26,720 | 13.65% | 5,242 | 61.31 |
| Lupin | 109,622 | 20.46 | 27,488 | 19.98% | 5,345 | 63.18 |
| Mankind Pharma | 102,848 | 53.06 | 14,278 | 12.03% | 1,750 | 57.28 |
| Aurobindo Pharma | 89,333 | 25.75 | 33,385 | 3.21% | 3,376 | 62.66 |
| Laurus Labs | 80,617 | 90.63 | 6,868 | 22.01% | 890 | 66.46 |
Parnax Lab Company Announcements - News Screener
Screen PARNAXLAB latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-07-03 | Closure of Trading Window | - |
| 2026-07-01 | Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations 2011 | - |
| 2026-07-01 | Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations 2011 | - |
| 2026-05-30 | Compliances-Reg.24(A)-Annual Secretarial Compliance | - |
| 2026-05-28 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-05-28 | Results For The Quarter And Year Ended March 2026 | - |
| 2026-05-28 | Board Meeting Outcome for Board Meeting Outcome For Consideration And Approval Of Standalone & Consolidated Audited Financial Results Of The Company For The Quarter And Year Ended 31St March 2026 Along With AuditorS Report Thereon. | - |
| 2026-05-20 | Board Meeting Intimation for Consideration And Approval Of Standalone And Consolidated Audited IND- AS Compliant Financial Results Along With Auditor Report For The Quarter (Q4) And Year Ended 31St March 2026 | - |
| 2026-04-08 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-03-27 | Closure of Trading Window | - |
| 2026-02-13 | Financial Results For The Quarter Ended December 31 2025. | - |
| 2026-02-13 | Financial Results For The Quarter Ended December 31 2025. | - |
| 2026-02-13 | Board Meeting Outcome for Outcome Of Board Meeting | - |
| 2026-02-05 | Board Meeting Intimation for Consideration And Approval Of Standalone And Consolidated Un-Audited Financial Results Along With Limited Review Report For The Quarter (Q3) And Nine Months Ended 31St December 2025. | - |
| 2026-01-22 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2025-12-31 | Closure of Trading Window | - |
| 2025-11-14 | Results For The Quarter Ended September 30 2025 | - |
| 2025-11-14 | Board Meeting Outcome for Outcome Of Board Meeting Dated 14Th November 2025 | - |
| 2025-11-03 | Board Meeting Intimation for Consideration And Approval Of Standalone And Consolidated Un-Audited IND- AS Compliant Financial Results Along With Limited Review Report For The Quarter (Q2) And Half Year Ended 30Th September 2025. | - |
| 2025-10-09 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |